全文获取类型
收费全文 | 2537篇 |
免费 | 164篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 110篇 |
妇产科学 | 41篇 |
基础医学 | 279篇 |
口腔科学 | 169篇 |
临床医学 | 164篇 |
内科学 | 472篇 |
皮肤病学 | 30篇 |
神经病学 | 364篇 |
特种医学 | 200篇 |
外国民族医学 | 1篇 |
外科学 | 317篇 |
综合类 | 54篇 |
一般理论 | 1篇 |
预防医学 | 123篇 |
眼科学 | 18篇 |
药学 | 182篇 |
中国医学 | 5篇 |
肿瘤学 | 187篇 |
出版年
2023年 | 11篇 |
2022年 | 30篇 |
2021年 | 42篇 |
2020年 | 35篇 |
2019年 | 35篇 |
2018年 | 45篇 |
2017年 | 51篇 |
2016年 | 59篇 |
2015年 | 68篇 |
2014年 | 69篇 |
2013年 | 111篇 |
2012年 | 120篇 |
2011年 | 127篇 |
2010年 | 122篇 |
2009年 | 106篇 |
2008年 | 122篇 |
2007年 | 93篇 |
2006年 | 108篇 |
2005年 | 89篇 |
2004年 | 75篇 |
2003年 | 78篇 |
2002年 | 74篇 |
2001年 | 77篇 |
2000年 | 70篇 |
1999年 | 60篇 |
1998年 | 51篇 |
1997年 | 52篇 |
1996年 | 42篇 |
1995年 | 52篇 |
1994年 | 37篇 |
1993年 | 28篇 |
1992年 | 42篇 |
1991年 | 53篇 |
1990年 | 40篇 |
1989年 | 47篇 |
1988年 | 41篇 |
1987年 | 45篇 |
1986年 | 43篇 |
1985年 | 35篇 |
1984年 | 26篇 |
1983年 | 26篇 |
1982年 | 16篇 |
1981年 | 17篇 |
1980年 | 24篇 |
1979年 | 23篇 |
1978年 | 23篇 |
1977年 | 9篇 |
1976年 | 19篇 |
1975年 | 9篇 |
1966年 | 10篇 |
排序方式: 共有2728条查询结果,搜索用时 15 毫秒
71.
72.
73.
Human papillomavirus‐related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection
下载免费PDF全文
![点击此处可从《International journal of urology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Alessandro Ginori Aurora Barone Rosa Santopietro Gabriele Barbanti Filippo Cecconi Sergio Antonio Tripodi 《International journal of urology》2015,22(2):222-225
Basaloid squamous cell carcinoma is a biologically aggressive neoplasm mainly found in the head and neck region. Recently, four cases of basaloid squamous cell carcinoma of the bladder have been reported, and three of them occurred in patients with neurogenic bladder, repeated catheterizations and human papillomavirus infection of the urinary tract. To the best of our knowledge, none of the patients affected by basaloid squamous cell carcinoma of the bladder described in the literature had documented genital involvement by human papillomavirus. Herein, we describe the case of a woman with neurogenic bladder affected by basaloid squamous cell carcinoma of the bladder and by a concomitant genital tract human papillomavirus infection. 相似文献
74.
Monika Dobrzyska-Mizera Monika Knitter Salvatore Mallardo Maria Cristina Del Barone Gabriella Santagata Maria Laura Di Lorenzo 《Materials》2021,14(10)
Bio-based composites made of poly(L-lactic acid) (PLLA) and β-cyclodextrin/d-limonene inclusion complex (CD-Lim) were prepared by melt extrusion. Encapsulation of volatile d-limonene molecules within β-cyclodextrin cages was proven to be a successful strategy to prevent evaporation during high-temperature processing. However, small amounts of limonene were released upon processing, resulting in the plasticization of the polymeric matrix. Morphological analysis revealed good dispersion of the filler, which acted as a nucleating agent, favoring the growth of PLLA crystals. The composites′ lowered glass transition temperature upon the addition of CD-Lim was also proved by thermomechanical analysis (DMA). Moreover, DMA revealed constant stiffness of modified materials at room temperature, which is crucial in PLLA-based formulations. 相似文献
75.
Genetic and non‐genetic factors that increase the risk of non‐syndromic cleft lip and/or palate development
下载免费PDF全文
![点击此处可从《Oral diseases》网站下载免费的PDF全文](/ch/ext_images/free.gif)
76.
Donor‐Derived Strongyloides stercoralis Infection in Solid Organ Transplant Recipients in the United States, 2009–2013
下载免费PDF全文
![点击此处可从《American journal of transplantation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
F. A. Abanyie E. B. Gray K. W. Delli Carpini A. Yanofsky I. McAuliffe M. Rana P. V. Chin‐Hong C. N. Barone J. L. Davis S. Huprikar 《American journal of transplantation》2015,15(5):1369-1375
Infection with Strongyloides stercoralis is typically asymptomatic in immunocompetent hosts, despite chronic infection. In contrast, immunocompromised hosts such as solid organ transplant recipients are at risk for hyperinfection syndrome and/or disseminated disease, frequently resulting in fatal outcomes. Infection in these recipients may result from reactivation of latent infection or infection through transmission from an infected donor. We describe the Centers for Disease Control and Prevention's experience with seven clusters of donor‐derived infection from 2009 to 2013. Six of the seven (86%) donors were born in Latin America; donor screening was not performed prior to organ transplantation in any of these investigations. Eleven of the 20 (55%) organ recipients were symptomatic, two of whom died from complications of strongyloidiasis. We also describe the New York Organ Donor Network (NYODN) experience with targeted donor screening from 2010 to 2013. Of the 233 consented potential donors tested, 10 tested positive for Strongyloides antibody; and 18 organs were transplanted. The majority (86%) of the donors were born in Central or South America. Fourteen recipients received prophylaxis after transplantation; no recipients developed strongyloidiasis. The NYODN experience provides evidence that when targeted donor screening is performed prior to transplantation, donor‐derived infection can be averted in recipients. 相似文献
77.
Antonio Facciorusso Valentina Del Prete Matteo Antonino Nicola Crucinio Viviana Neve Alfredo Di Leo Brian I. Carr Michele Barone 《Digestive and liver disease》2014,46(11):1014-1019
Background
Overall survival in hepatocellular carcinoma patients treated with percutaneous radiofrequency ablation is influenced by both recurrence and successive treatments. We investigated post-recurrence survival after radiofrequency ablation.Methods
Data on 103 early/intermediate patients initially treated with radiofrequency ablation and followed for a median of 78 months (range 68–82) were retrospectively analysed. If intrahepatic disease recurrence occurred within or contiguous to the previously treated area it was defined as local, otherwise as distant; recurrence classified as Barcelona Clinic Liver Cancer stage C was defined by neoplastic portal vein thrombosis or metastases.Results
A total of 103 patients were included (82.5% male; median age 70 years, range 39–86). During follow-up, 64 recurrences were observed. Median overall survival was 62 months (95% confidence interval: 54–78) and survival rates were 97%, 65% and 52% at 1, 4 and 5 years, respectively. Median post-recurrence survival was 22 months (95% confidence interval: 16–35). Child–Pugh score, performance status, sum of tumour diameters at recurrence and recurrence patterns were independent predictors of post-recurrence survival.Conclusions
In patients with hepatocellular carcinoma after radiofrequency ablation, clinical and tumour parameters assessed at relapse, in particular the type of recurrence pattern, influence post-recurrence survival. 相似文献78.
Brian J. Kolowitz Gonzalo Romero Lauro James Venturella Veliyan Georgiev Michael Barone Christopher Deible Rasu Shrestha 《Journal of digital imaging》2014,27(2):192-199
The adoption of social media technologies appears to enhance clinical outcomes through improved communications as reported by Bacigalupe (Fam Syst Heal 29(1):1-14, 2011). The ability of providers to more effectively, directly, and rapidly communicate among themselves as well as with patients should strengthen collaboration and treatment as reported by Bacigalupe (Fam Syst Heal 29(1):1-14, 2011). This paper is a case study in one organization's development of an internally designed and developed social technology solution termed “Unite.” The Unite system combines social technologies' features including push notifications, messaging, community groups, and user lists with clinical workflow and applications to construct dynamic provider networks, simplify communications, and facilitate clinical workflow optimization. Modeling Unite as a social technology may ease adoption barriers. Developing a social network that is integrated with healthcare information systems in the clinical space opens the doors to capturing and studying the way in which providers communicate. The Unite system appears to have the potential to breaking down existing communication paradigms. With Unite, a rich set of usage data tied to clinical events may unravel alternative networks that can be leveraged to advance patient care. 相似文献
79.
80.
Michele Barone Andrea Iannone Alfredo Di Leo 《World journal of gastroenterology : WJG》2014,20(26):8722-8725
The ideal endpoint of hepatitis B virus (HBV) antiviral therapy is HBsAg loss, a difficult goal to obtain, especially in HBeAg negative patients. Herein, we report the results obtained by the addition of peg-interferon α-2a to a long-lasting nucleos(t)ide analogue therapy in a HBeAg negative, genotype D patient with steadily HBV-DNA negative/HBsAg positive values. In 2002, our Caucasian 44-year-old male patient received lamivudine and, 4 years later, added adefovir because of a virological breakthrough. In 2011, considering his young age, liver stiffness (4.3 kPa) and HBsAg levels (3533 IU/mL), we added Peg-interferon α-2a for six months (3 in combination with nucleos(t)ide analogues followed by 3 mo of Peg-interferon α-2a monotherapy). A decrease of HBsAg levels was observed after 1 mo (1.21 log) of Peg-interferon and 3 mo (1.88 log) after the discontinuation of all drugs. Later, a complete clearance of HBsAg was obtained with steadily undetectable HBV-DNA serum levels (< 9 IU/mL). HBsAg clearance by the addition of a short course of Peg-interferon α-2a represents an important result with clinical and pharmaco-economic implications, considering that nucleos(t)ide analogues therapy in HBeAg negative chronic hepatitis B patients is considered a long-lasting/life-long treatment. 相似文献